DAY ONE BIOPHARMACEUTICALS INC. - COMMON STOCK
13.72
22-November-24 16:44:58
15 minutes delayed
Stocks
+0.38
+2.85%
Today's range
13.28 - 13.91
ISIN
N/A
Source
NASDAQ
-
Day One Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development
20 Nov 2024 16:30:00 By Nasdaq GlobeNewswire
-
Day One to Participate in the Piper Sandler 36th Annual Healthcare Conference
18 Nov 2024 08:30:00 By Nasdaq GlobeNewswire
-
Day One Reports Third Quarter 2024 Financial Results and Corporate Progress
30 Oct 2024 16:01:00 By Nasdaq GlobeNewswire
-
Day One to Report Third Quarter 2024 Financial Results Wednesday, October 30, 2024
16 Oct 2024 08:30:00 By Nasdaq GlobeNewswire
-
Day One Reports Second Quarter 2024 Financial Results and Corporate Progress
30 Jul 2024 07:30:00 By Nasdaq GlobeNewswire
-
Day One Announces Oversubscribed $175.0 Million Private Placement
30 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
-
18 Jun 2024 08:30:00 By Nasdaq GlobeNewswire
-
Day One Announces Sale of Priority Review Voucher for $108 Million
30 May 2024 08:30:00 By Nasdaq GlobeNewswire
-
Day One Reports First Quarter 2024 Financial Results and Corporate Progress
06 May 2024 16:30:00 By Nasdaq GlobeNewswire
-
Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress
26 Feb 2024 16:30:00 By Nasdaq GlobeNewswire
-
Day One Announces Two New Appointments to Board of Directors
17 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
Day One to Present at the 42nd Annual J.P. Morgan Healthcare Conference
19 Dec 2023 08:00:00 By Nasdaq GlobeNewswire
-
Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine
17 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
Day One to Participate in the Piper Sandler 35th Annual Healthcare Conference
14 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
Day One Reports Third Quarter 2023 Financial Results and Corporate Progress
06 Nov 2023 16:30:05 By Nasdaq GlobeNewswire
-
30 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
11 Sep 2023 08:30:00 By Nasdaq GlobeNewswire
-
Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience
16 Aug 2023 08:00:00 By Nasdaq GlobeNewswire
-
Day One Reports Second Quarter 2023 Financial Results and Corporate Progress
07 Aug 2023 16:30:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >